Cargando…
A pilot study of oxidative pathways in MS fatigue: randomized trial of N‐acetyl cysteine
OBJECTIVE: To assess feasibility, tolerability, and safety of N‐acetyl cysteine (NAC) for fatigue in progressive MS. Secondary objectives evaluated changes in fatigue and oxidative pathway biomarkers on NAC versus placebo. METHODS: Individuals with progressive MS with Modified Fatigue Impact Scale (...
Autores principales: | Krysko, Kristen M., Bischof, Antje, Nourbakhsh, Bardia, Henry, Roland G., Revirajan, Nisha, Manguinao, Michael, Nguyen, Khang, Akula, Amit, Li, Yan, Waubant, Emmanuelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045913/ https://www.ncbi.nlm.nih.gov/pubmed/33675156 http://dx.doi.org/10.1002/acn3.51325 |
Ejemplares similares
-
Biosensor vital sign detects multiple sclerosis progression
por: Krysko, Kristen M., et al.
Publicado: (2020) -
Novel MS vital sign: multi‐sensor captures upper and lower limb dysfunction
por: Akhbardeh, Alireza, et al.
Publicado: (2020) -
Altered tryptophan metabolism is associated with pediatric multiple sclerosis risk and course
por: Nourbakhsh, Bardia, et al.
Publicado: (2018) -
Susceptibility-based imaging aids accurate distinction of pediatric-onset MS from myelin oligodendrocyte glycoprotein antibody-associated disease
por: Sacco, Simone, et al.
Publicado: (2023) -
A randomized controlled phase II trial of riluzole in early multiple sclerosis
por: Waubant, Emmanuelle, et al.
Publicado: (2014)